awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36287386-18B30342-D5CD-4543-B126-F5E600CA698E
Q36287386-18B30342-D5CD-4543-B126-F5E600CA698E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36287386-18B30342-D5CD-4543-B126-F5E600CA698E
A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.
P2860
Q36287386-18B30342-D5CD-4543-B126-F5E600CA698E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36287386-18B30342-D5CD-4543-B126-F5E600CA698E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
787a360abd28e74104fe62844255ff22be08f86b
P2860
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.